An interactive pharmacokinetic-pharmacodynamic model for patientspecific HIV treatment guidelines.

被引：0
|
作者：
Gajendran, V.
Kahn, J.
Mehta, M.
机构：
[1] Univ Calif Davis, Davis, CA 95616 USA
[2] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2007年 / 55卷 / 01期
关键词：
D O I：
10.1097/00042871-200701010-00428
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S145 / S145
页数：1
相关论文
共 50 条
  • [21] A Population Pharmacokinetic-Pharmacodynamic Model for Allopurinol in Patients with Gout
    Wright, Daniel F. B.
    Duffull, Stephen B.
    Merriman, Tony R.
    Barclay, Murray L.
    Stamp, Lisa K.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S33 - S33
  • [22] Atazanavir-bilirubin interaction: a pharmacokinetic-pharmacodynamic model
    Lozano, Roberto
    Domeque, Nieves
    Apesteguia, Alberto-Fermin
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 153 - 159
  • [23] Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis
    Kloprogge, Frank
    Mwandumba, Henry C.
    Banda, Gertrude
    Kamdolozi, Mercy
    Shani, Doris
    Corbett, Elizabeth L.
    Kontogianni, Nadia
    Ward, Steve
    Khoo, Saye H.
    Davies, Geraint R.
    Sloan, Derek J.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (07):
  • [24] PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF MAGNESIUM-SULFATE IN TREATMENT OF PREGNANCY-INDUCED HYPERTENSION
    CHEN, G
    LU, JF
    CAO, W
    ACTA PHARMACOLOGICA SINICA, 1991, 12 (03): : 222 - 225
  • [25] Guiding Dyslipidemia Treatment: A Population Pharmacokinetic-Pharmacodynamic Framework for Obicetrapib
    Dunn, Allison
    Ditmarsch, Marc
    Kastelein, John J. P.
    Kling, Douglas
    Neild, Annie
    Davidson, Michael H.
    Gobburu, Joga
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (09) : 1150 - 1164
  • [26] Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model
    Sridharan, Kannan
    Al Banna, Rashed
    Husain, Aysha
    ADMET AND DMPK, 2021, 9 (02): : 143 - 149
  • [27] A pharmacokinetic-pharmacodynamic model of acute tolerance to the subjective effects of alcohol
    Ramchandani, VA
    Hoefer, ME
    Edenberg, EF
    Walker, JT
    Hommer, DW
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 66A - 66A
  • [28] A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity
    Heetla, H. W.
    Proost, J. H.
    Molmans, B. H.
    Staal, M. J.
    van Laar, T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (01) : 101 - 112
  • [29] An Adaptation of the Eleveld Pharmacokinetic-Pharmacodynamic Model for a Burst Suppression Endpoint
    Lybbert, Carter
    Mickey, Brian J.
    Jones, Keith G.
    Odell, David
    Stanford, Jordan
    Tadler, Scott C.
    Huang, Jason
    Kuck, Kai
    ANESTHESIA AND ANALGESIA, 2023, 136 : 34 - 35
  • [30] Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation
    Eleveld, D. J.
    Colin, P.
    Absalom, A. R.
    Struys, M. M. R. F.
    BRITISH JOURNAL OF ANAESTHESIA, 2018, 120 (05) : 942 - 959
12345